Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors

Published:2014-10 Issue:1-2 Volume:474 Page:151-156
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Ochi Masanori^ORCID,Kawachi Takaki,Toita Eri,Hashimoto Issei,Yuminoki Kayo,Onoue Satomi,Hashimoto Naofumi

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. Freeze-drying of nanoparticles: formulation, process and storage considerations;Abdelwahed;Adv. Drug Deliv. Rev.,2006

2. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation;Alladi;Arch. Pharm. Res.,2014

3. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm. Res.,1995

4. Premedication with cyclooxygenase-2 inhibitor meloxicam reduced postoperative pain in patients after oral surgery;Aoki;Int. J. Oral Maxillofac. Surg.,2006

5. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions;Chauhan;J. Pharm. Sci.,2013

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers;Clinical Pharmacology in Drug Development;2024-09-05

2. Recent developments in the use of nanocrystals to improve bioavailability of APIs;WIREs Nanomedicine and Nanobiotechnology;2024-03

3. Nanoparticle preparation of pharmaceutical compounds via wet milling: Current status and future prospects;Powder Technology;2024-02

4. Amorphous solid dispersions of triclabendazole: Keeping the supersaturated drug solution using poloxamers;Journal of Drug Delivery Science and Technology;2024-01

5. Novel oxicam nonsteroidal compound XK01 attenuates inflammation by suppressing the NF-κB and MAPK pathway in RAW264.7 macrophages;Heliyon;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3